COLLCOLLEGIUM PHARMACEUTICAL, INC

Nasdaq collegiumpharma.com


$ 36.40 $ 0.58 (1.62 %)    

Friday, 26-Apr-2024 15:59:55 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 36.42
$ 36.10
$ 0.00 x 0
$ 0.00 x 0
$ 36.10 - $ 36.52
$ 20.83 - $ 40.95
252,821
na
1.52B
$ 0.94
$ 31.60
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-22-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-23-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 02-24-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 02-25-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-05-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 02-27-2020 12-31-2019 10-K
18 11-06-2019 09-30-2019 10-Q
19 08-07-2019 06-30-2019 10-Q
20 05-08-2019 03-31-2019 10-Q
21 02-27-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-08-2018 06-30-2018 10-Q
24 05-09-2018 03-31-2018 10-Q
25 03-07-2018 12-31-2017 10-K
26 11-08-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 03-10-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 05-11-2016 03-31-2016 10-Q
33 03-18-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 08-12-2015 06-30-2015 10-Q
36 06-22-2015 03-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-buy-on-collegium-pharmaceutical-maintains-40-price-target

Needham analyst Serge Belanger reiterates Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and maintains $40 price target.

 truist-securities-maintains-buy-on-collegium-pharmaceutical-raises-price-target-to-40

Truist Securities analyst Les Sulewski maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price targ...

 collegium-pharmaceutical-q4-2023-adj-eps-158-beats-066-estimate-sales-14975m-beat-14782m-estimate

Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate...

 earnings-scheduled-for-february-22-2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

 needham-reiterates-buy-on-collegium-pharmaceutical-maintains-40-price-target

Needham analyst Serge Belanger reiterates Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and maintains $40 price target.

 needham-maintains-buy-on-collegium-pharmaceutical-raises-price-target-to-40

Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price target from ...

 truist-securities-maintains-buy-on-collegium-pharmaceutical-raises-price-target-to-37

Truist Securities analyst Gregg Gilbert maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price tar...

 jefferies-downgrades-collegium-pharmaceutical-to-hold-raises-price-target-to-37

Jefferies analyst Glen Santangelo downgrades Collegium Pharmaceutical (NASDAQ:COLL) from Buy to Hold and raises the price ta...

 why-collegium-pharmaceutical-shares-are-gaining-today

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial 

 tdcx-receives-preliminary-non-binding-proposal-letter-joins-pure-storage-dyne-therapeutics-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) r...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION